Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
29.06.2018 - 20.07.2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
28 July 2015
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Version / remarks:
Jul-2012
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
EC Number:
252-939-2
EC Name:
Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
Cas Number:
36265-41-5
Molecular formula:
C33H59NO4
IUPAC Name:
didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
Test material form:
solid: particulate/powder

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Value:
> 50
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation

Any other information on results incl. tables

In the present study the skin irritant potential of Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-

dicarboxylate was analysed. The EpiDerm™-Standard Model (EPI-200™), a reconstituted threedimensional

human epidermis model, was used as a replacement for the Draize Skin Irritation Test

(OECD TG 404, [7]) to distinguish between UN GHS “Category 2” skin irritating test substances and

not categorized test substances (“No Category”) which may be considered as non-irritant. Hereby,

the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial

dehydrogenase activity measured by formazan production from MTT after a 60 min exposure and

42 h post-incubation period and compared to those of the concurrent negative controls.

The mixture of 25 mg test item per 1 mL MTT medium showed no reduction of MTT compared to the

solvent. The mixture did not turn blue/purple. Therefore, NSMTT equalled 0%.

The mixture of 25 mg of the test item per 300 μl aqua dest. showed no colouring detectable by

unaided eye-assessment. The mixture of 25 mg of the test item per 300 μl isopropanol showed

colouring detectable by unaided eye-assessment. Therefore, the absorption of the chemical in

isopropanol was measured in the range of 570 ± 30 nm. No absorption was measured in the

relevant range (see Figure 1). Therefore, NSC equalled 0%.

The test item showed no irritant effects. The mean relative tissue viability (% negative control) was

> 50% (109.8%) after 60 min treatment and 42 h post-incubation.

8.2. Conclusion

In this study under the given conditions the test item showed no irritant effects. The relative mean

tissue viability after 60 min of exposure and 42 h post-incubation was > 50%. The test item is

therefore classified as “non-irritant” in accordance with UN GHS “No Category”.

Applicant's summary and conclusion